Imatinib mesylate inhibits the profibrogenic activity of TGF-β and prevents bleomycin-mediated lung fibrosisCraig Daniels(West Virginia University), Edward B. Leof(Mayo Clinic)Journal of Clinical InvestigationNovember 1, 200410.1172/jci19603Cited by 525SaveCiteExport RISWatch citationsRelated PapersIntertumoral Heterogeneity within Medulloblastoma Subgroups|Cancer Cell|2017|1.3kTransforming Growth Factor-β Activation of Phosphatidylinositol 3-Kinase Is Independent of Smad2 and Smad3 and Regulates Fibroblast Responses via p21-Activated Kinase-2|Cancer Research|2005|212